ECSDI045123S - - Google Patents

Info

Publication number
ECSDI045123S
ECSDI045123S EC2004005123F ECSDI045123F ECSDI045123S EC SDI045123 S ECSDI045123 S EC SDI045123S EC 2004005123 F EC2004005123 F EC 2004005123F EC SDI045123 F ECSDI045123 F EC SDI045123F EC SDI045123 S ECSDI045123 S EC SDI045123S
Authority
EC
Ecuador
Application number
EC2004005123F
Other languages
Spanish (es)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of ECSDI045123S publication Critical patent/ECSDI045123S/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49Urokinase; Tissue plasminogen activator
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Surgery (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Detergent Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EC2004005123F 2001-11-26 2004-05-26 ECSDI045123S (h)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33336901P 2001-11-26 2001-11-26

Publications (1)

Publication Number Publication Date
ECSDI045123S true ECSDI045123S (h) 2004-07-23

Family

ID=23302492

Family Applications (2)

Application Number Title Priority Date Filing Date
EC2004005123A ECSP045123A (es) 2001-11-26 2004-05-26 Composición para catéteres y sus usos
EC2004005123F ECSDI045123S (h) 2001-11-26 2004-05-26

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EC2004005123A ECSP045123A (es) 2001-11-26 2004-05-26 Composición para catéteres y sus usos

Country Status (28)

Country Link
US (3) US20030206906A1 (h)
EP (1) EP1455858A4 (h)
JP (1) JP4458240B2 (h)
KR (2) KR20100102745A (h)
CN (1) CN100478027C (h)
AR (1) AR037437A1 (h)
AU (2) AU2002365408B2 (h)
BR (1) BR0215098A (h)
CA (1) CA2467645C (h)
CO (1) CO5580795A2 (h)
EA (1) EA007594B1 (h)
EC (2) ECSP045123A (h)
HR (1) HRP20040502A2 (h)
HU (1) HUP0600436A3 (h)
IL (2) IL162083A0 (h)
IS (1) IS7275A (h)
ME (1) ME00015B (h)
MX (1) MXPA04004948A (h)
MY (1) MY140404A (h)
NO (1) NO331700B1 (h)
NZ (1) NZ533029A (h)
PL (1) PL371760A1 (h)
RS (1) RS46204A (h)
TW (1) TWI262794B (h)
UA (1) UA81235C2 (h)
UY (1) UY27550A1 (h)
WO (1) WO2003045466A2 (h)
ZA (1) ZA200404024B (h)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ533029A (en) * 2001-11-26 2006-05-26 Genentech Inc Composition useful for removal of fibrin-bound blood clot from a catheter comprises water, a plasminogen activator and an alcohol
US7128923B2 (en) * 2003-03-31 2006-10-31 Procyte Corporation Preserved and stable compositions containing peptide copper complexes and method related thereto
EA016250B1 (ru) 2006-08-28 2012-03-30 Омнио Хилер Аб Применение плазминогена для лечения инфекционных заболеваний
EP2056865B1 (en) * 2006-08-28 2013-12-25 Omnio Healer AB Novel drug target of preventing and treating periodontal disease, improving healing of periodontal wounds and promoting oral health
CA2668347C (en) * 2006-11-07 2017-06-20 Genentech, Inc. Tissue plasminogen activator variant uses
RU2323001C1 (ru) * 2007-05-30 2008-04-27 Общество с ограниченной ответственностью "Научно-производственное предприятие "Техноген" Фармацевтическая композиция, обладающая фибринолитическим действием
JP5642540B2 (ja) 2007-06-01 2014-12-17 アロウ・インターナショナル・インコーポレイテッドArrow International, Inc. 組み合わされた線維素溶解性および抗菌性のカテーテル、およびその使用
CN101827612A (zh) * 2007-09-07 2010-09-08 联合治疗公司 针对革兰氏阴性细菌具有选择性杀菌活性的缓冲液及其使用方法
US8545459B2 (en) * 2009-02-25 2013-10-01 Teleflex Medical Incorporated Stabilized enzyme compositions
US9333280B2 (en) 2009-02-25 2016-05-10 Teleflex Medical Incorporated Stabilized enzyme compositions
US20110213025A1 (en) * 2009-08-10 2011-09-01 Proviflo, Llc Catheter Lock Solutions Utilizing Tocopherol and Mid-Chain Fatty Acids
CN103083726A (zh) * 2013-03-04 2013-05-08 昆明市第一人民医院 一种肝脏组织脱细胞液
US10456570B2 (en) 2015-06-11 2019-10-29 Proviflo, Llc Graft-port hemodialysis systems, devices, and methods

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI831484L (fi) * 1982-05-05 1983-11-06 Genentech Inc Plasminogen aktivator foer maenskovaevnad
US5000185A (en) * 1986-02-28 1991-03-19 Cardiovascular Imaging Systems, Inc. Method for intravascular two-dimensional ultrasonography and recanalization
US5019096A (en) * 1988-02-11 1991-05-28 Trustees Of Columbia University In The City Of New York Infection-resistant compositions, medical devices and surfaces and methods for preparing and using same
US5270198A (en) * 1988-05-20 1993-12-14 Genentech, Inc. DNA molecules encoding variants of tissue plasminogen activators, vectors, and host cells
GB8820945D0 (en) * 1988-09-07 1988-10-05 Smith & Nephew Medical articles
FR2661790B1 (fr) * 1990-05-03 1995-08-25 France Etat Dispositif d'amplification tres large bande continu-hyperfrequences, notamment realisable en circuit integre.
WO1991017724A1 (en) * 1990-05-17 1991-11-28 Harbor Medical Devices, Inc. Medical device polymer
US5399158A (en) * 1990-05-31 1995-03-21 The United States Of America As Represented By The Secretary Of The Army Method of lysing thrombi
US5363754A (en) * 1991-09-03 1994-11-15 Grainco Queensland Co-Operative Association Limited Apparatus for preparing animal feedstuff from cotton seed
JPH05291891A (ja) * 1992-02-14 1993-11-05 Ricoh Co Ltd 一次乱数パルス列発生回路装置
WO1993024635A1 (en) * 1992-06-03 1993-12-09 Genentech, Inc. Tissue plasminogen activator glycosylation variants with improved therapeutic properties
US5688516A (en) * 1992-11-12 1997-11-18 Board Of Regents, The University Of Texas System Non-glycopeptide antimicrobial agents in combination with an anticoagulant, an antithrombotic or a chelating agent, and their uses in, for example, the preparation of medical devices
US5362754A (en) 1992-11-12 1994-11-08 Univ. Of Tx Md Anderson Cancer Center M-EDTA pharmaceutical preparations and uses thereof
US5849736A (en) * 1993-11-24 1998-12-15 The Dupont Merck Pharmaceutical Company Isoxazoline and isoxazole fibrinogen receptor antagonists
ATE198748T1 (de) 1993-11-24 2001-02-15 Du Pont Pharm Co Isoxazoline und isoxazole derivate als fibrinogen rezeptor antagonisten
US5885967A (en) * 1994-03-04 1999-03-23 Eli Lilly And Company Antithrombotic agents
US5509896A (en) * 1994-09-09 1996-04-23 Coraje, Inc. Enhancement of thrombolysis with external ultrasound
CA2178541C (en) * 1995-06-07 2009-11-24 Neal E. Fearnot Implantable medical device
US5772640A (en) * 1996-01-05 1998-06-30 The Trustees Of Columbia University Of The City Of New York Triclosan-containing medical devices
US5932299A (en) * 1996-04-23 1999-08-03 Katoot; Mohammad W. Method for modifying the surface of an object
US5840733A (en) * 1996-07-01 1998-11-24 Redcell, Canada, Inc. Methods and compositions for producing novel conjugates of thrombin inhibitors and endogenous carriers resulting in anti-thrombins with extended lifetimes
US5837688A (en) * 1996-11-27 1998-11-17 Gelfand; Mathew I. Use of thrombolytic reagents for prevention of vascular disease
AU5526098A (en) 1996-12-23 1998-07-17 Biochem Pharma Inc. Bicyclic thrombin inhibitors
GB9626795D0 (en) * 1996-12-23 1997-02-12 Geistlich Soehne Ag Combating infection in delivery systems
US5981826A (en) * 1997-05-05 1999-11-09 Georgia Tech Research Corporation Poly(vinyl alcohol) cryogel
JPH10328293A (ja) 1997-06-04 1998-12-15 Unitika Ltd 医療用具及びその製造方法
US6206914B1 (en) * 1998-04-30 2001-03-27 Medtronic, Inc. Implantable system with drug-eluting cells for on-demand local drug delivery
US6166007A (en) * 1998-07-02 2000-12-26 Sodemann; Klaus Antimicrobial locks comprising taurinamide derivatives and carboxylic acids and/or salts thereof
US6174537B1 (en) * 1998-09-25 2001-01-16 Becton, Dickinson And Company Catheter flush solution and method for its use
EA200100965A1 (ru) * 1999-03-11 2002-08-29 Дюпон Фармасьютикалз Компани Синергизм между низкомолекулярным гепарином и ингибиторами агрегации тромбоцитов, обеспечивающий комбинированную терапию для профилактики и лечения различных тромбоэмболических нарушений
EA200100966A1 (ru) 1999-03-11 2002-02-28 Дюпон Фармасьютикалз Компани ЛЕЧЕНИЕ ТРОМБОЗА КОМБИНИРОВАННЫМ ПРИМЕНЕНИЕМ ИНГИБИТОРА ФАКТОРА Xa И АСПИРИНА, АКТИВАТОРА ТКАНЕВОГО ПЛАЗМИНОГЕНА (TPA), АНТАГОНИСТА GPIIB/IIIA, НИЗКОМОЛЕКУЛЯРНОГО ГЕПАРИНА ИЛИ ГЕПАРИНА
CA2302720C (en) 1999-03-29 2009-07-14 Ed Geistlich Sohne Ag Fur Chemische Industrie Anticoagulant/sterilizing compositions and methods
US6187768B1 (en) * 1999-06-01 2001-02-13 Becton, Dickinson And Company Kit for flushing medical devices and method of preparation
EP1060747A3 (en) * 1999-06-16 2001-12-05 New York Blood Center, Inc. Fibrin(ogen) degradation and clot lysis by fibrinolytic metalloproteinase
US6592564B2 (en) * 1999-07-23 2003-07-15 Vasca, Inc. Methods and kits for locking and disinfecting implanted catheters
US6350251B1 (en) * 2000-01-18 2002-02-26 Biolink Corporation Biocidal locks
US20010031981A1 (en) * 2000-03-31 2001-10-18 Evans Michael A. Method and device for locating guidewire and treating chronic total occlusions
JP2005517460A (ja) 2000-05-10 2005-06-16 アッシュ・アクセス・テクノロジー・インコーポレーテッド 光酸化剤を含むカテーテルロック溶液
US6772640B1 (en) * 2000-10-10 2004-08-10 Mks Instruments, Inc. Multi-temperature heater for use with pressure transducers
US20050215978A1 (en) * 2001-05-25 2005-09-29 Ash Stephen R Method of enhancing catheter patency using a citrate salt catheter lock solution
NZ533029A (en) * 2001-11-26 2006-05-26 Genentech Inc Composition useful for removal of fibrin-bound blood clot from a catheter comprises water, a plasminogen activator and an alcohol
US20070014779A1 (en) * 2002-11-14 2007-01-18 Genentech, Inc. Plasminogen activator variant formulations
ES2282529T3 (es) 2003-02-03 2007-10-16 Hans-Dietrich Dr.Techn. Polaschegg Composicion para la prevencion de una infeccion debida a un dispositi vo permanente.
US7696182B2 (en) 2004-11-02 2010-04-13 Nd Partners, Llc Antimicrobial locking solutions comprising taurinamide derivatives and biologically acceptable salts and acids, with the addition of small concentrations of heparin
US7749529B2 (en) 2005-02-08 2010-07-06 Ash Access Technology, Inc. Catheter lock solution comprising citrate and a paraben
CA2668347C (en) 2006-11-07 2017-06-20 Genentech, Inc. Tissue plasminogen activator variant uses

Also Published As

Publication number Publication date
IS7275A (is) 2004-05-21
WO2003045466A2 (en) 2003-06-05
ZA200404024B (en) 2005-07-27
CN100478027C (zh) 2009-04-15
BR0215098A (pt) 2004-12-14
CN1617738A (zh) 2005-05-18
HRP20040502A2 (en) 2004-12-31
MY140404A (en) 2009-12-31
WO2003045466A3 (en) 2003-10-09
US7829082B2 (en) 2010-11-09
US20060257390A1 (en) 2006-11-16
TW200303743A (en) 2003-09-16
NZ533029A (en) 2006-05-26
PL371760A1 (en) 2005-06-27
AU2002365408A1 (en) 2003-06-10
MXPA04004948A (es) 2004-08-11
US20030206906A1 (en) 2003-11-06
UA81235C2 (en) 2007-12-25
CO5580795A2 (es) 2005-11-30
EP1455858A2 (en) 2004-09-15
RS46204A (en) 2006-10-27
HUP0600436A3 (en) 2010-12-28
IL162083A (en) 2012-12-31
JP2005510302A (ja) 2005-04-21
CA2467645C (en) 2017-01-17
AU2008203131A1 (en) 2008-08-07
AR037437A1 (es) 2004-11-10
KR20100102745A (ko) 2010-09-24
KR20040054803A (ko) 2004-06-25
JP4458240B2 (ja) 2010-04-28
HUP0600436A2 (en) 2006-09-28
ME00015B (me) 2010-06-10
NO20042693L (no) 2004-08-25
EA200400712A1 (ru) 2005-06-30
NO331700B1 (no) 2012-02-27
UY27550A1 (es) 2003-06-30
US20060246050A1 (en) 2006-11-02
TWI262794B (en) 2006-10-01
ECSP045123A (es) 2004-07-23
MEP8008A (xx) 2010-02-10
AU2002365408B2 (en) 2008-04-24
IL162083A0 (en) 2005-11-20
EA007594B1 (ru) 2006-12-29
CA2467645A1 (en) 2003-06-05
EP1455858A4 (en) 2006-02-15

Similar Documents

Publication Publication Date Title
BE2022C531I2 (h)
BE2022C502I2 (h)
BE2022C547I2 (h)
BE2017C056I2 (h)
BE2017C051I2 (h)
BE2017C032I2 (h)
BE2017C050I2 (h)
JP2002168661A5 (h)
BRPI0209186B1 (h)
BRPI0204884A2 (h)
CH1379220H1 (h)
JP2001225819A5 (h)
JP2002031931A5 (h)
BRPI0101486B8 (h)
JP2002236419A5 (h)
BRPI0210463A2 (h)
JP2002247923A5 (h)
JP2002056487A5 (h)
AU2000280389A8 (h)
JP2002251280A5 (h)
JP2002206566A5 (h)
JP2002229704A5 (h)
JP2002207158A5 (h)
JP2002108313A5 (h)
BRMU8103221U (h)